Exogenous melatonin as a disease-modifying therapy for epilepsy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

P14: Mitochondria as a Target for Drug Therapy in Epilepsy

لطفاً به چکیده انگلیسی مراجعه شود.

متن کامل

SSRIs as Disease - Modifying Therapy for Alzheimer Disease

A. Study Purpose and Rationale Alzheimer Disease (AD), characterized by a gradual and progressive decline in cognition and behavior with prominent early memory dysfunction, is the most common form of dementia in older adults. It represents a significant burden worldwide for health care systems. In 2000, an estimated 4.5 million people in the US were afflicted with AD, and projections suggest th...

متن کامل

Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons

Systemic sclerosis (SSc; scleroderma) is an autoimmune connective tissue disorder characterized by microvasculopathy, excessive collagen deposition and autoimmunity. It can affect virtually any organ with the skin, heart, lungs, kidneys and gastrointestinal systems most commonly involved. Early studies have indicated that patients with early active diffuse cutaneous SSc (dcSSc) and significant ...

متن کامل

Gold Finger: Metal Jewellery as a Disease Modifying Antirheumatic Therapy!

Polyarticular psoriatic arthritis is a chronic, progressive and disabling auto-immune disease often affecting the small joints of the hands in a symmetrical fashion. The disease can progress rapidly causing joint swelling and damaging cartilage and bone around the joints resulting in severe deformities. We report a very unusual case of a 49-year-old woman who presented with polyarticular psoria...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Epilepsy and paroxysmal conditions

سال: 2019

ISSN: 2311-4088,2077-8333

DOI: 10.17749/2077-8333.2019.11.2.124-141